Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9AYM6
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.530 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.545 |
CLV_NRD_NRD_1 | 120 | 122 | PF00675 | 0.505 |
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.435 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.635 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.545 |
CLV_PCSK_FUR_1 | 216 | 220 | PF00082 | 0.624 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.530 |
CLV_PCSK_KEX2_1 | 124 | 126 | PF00082 | 0.446 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.522 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.704 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.532 |
CLV_PCSK_PC1ET2_1 | 200 | 202 | PF00082 | 0.522 |
CLV_PCSK_PC1ET2_1 | 32 | 34 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.552 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.364 |
DEG_APCC_DBOX_1 | 124 | 132 | PF00400 | 0.593 |
DEG_APCC_KENBOX_2 | 181 | 185 | PF00400 | 0.454 |
DEG_SPOP_SBC_1 | 140 | 144 | PF00917 | 0.500 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.546 |
DOC_USP7_MATH_2 | 105 | 111 | PF00917 | 0.609 |
LIG_14-3-3_CanoR_1 | 149 | 157 | PF00244 | 0.370 |
LIG_14-3-3_CanoR_1 | 187 | 192 | PF00244 | 0.314 |
LIG_BIR_III_2 | 102 | 106 | PF00653 | 0.445 |
LIG_BIR_III_2 | 82 | 86 | PF00653 | 0.488 |
LIG_CtBP_PxDLS_1 | 2 | 6 | PF00389 | 0.478 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.380 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.614 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.455 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.463 |
LIG_LIR_Gen_1 | 38 | 48 | PF02991 | 0.494 |
LIG_LIR_Gen_1 | 67 | 75 | PF02991 | 0.569 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 38 | 43 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 67 | 71 | PF02991 | 0.470 |
LIG_NRBOX | 26 | 32 | PF00104 | 0.473 |
LIG_PCNA_yPIPBox_3 | 23 | 33 | PF02747 | 0.527 |
LIG_SH2_CRK | 157 | 161 | PF00017 | 0.499 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.405 |
LIG_TRAF2_1 | 110 | 113 | PF00917 | 0.625 |
LIG_TYR_ITIM | 155 | 160 | PF00017 | 0.500 |
LIG_UBA3_1 | 26 | 32 | PF00899 | 0.434 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.398 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.682 |
MOD_CK2_1 | 140 | 146 | PF00069 | 0.509 |
MOD_Cter_Amidation | 146 | 149 | PF01082 | 0.452 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.581 |
MOD_GlcNHglycan | 133 | 136 | PF01048 | 0.610 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.497 |
MOD_GlcNHglycan | 204 | 208 | PF01048 | 0.605 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.616 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.361 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.417 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.653 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.505 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.532 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.382 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.561 |
MOD_PIKK_1 | 191 | 197 | PF00454 | 0.544 |
MOD_PKB_1 | 201 | 209 | PF00069 | 0.470 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.570 |
MOD_Plk_2-3 | 141 | 147 | PF00069 | 0.636 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.390 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.572 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.500 |
TRG_ER_diArg_1 | 216 | 219 | PF00400 | 0.672 |
TRG_NES_CRM1_1 | 4 | 17 | PF08389 | 0.446 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7L0 | Leptomonas seymouri | 63% | 100% |
A0A0S4JIP0 | Bodo saltans | 32% | 100% |
A0A1X0P7J1 | Trypanosomatidae | 41% | 78% |
A0A3S7X077 | Leishmania donovani | 92% | 100% |
A0A422P3P4 | Trypanosoma rangeli | 45% | 87% |
A4HF90 | Leishmania braziliensis | 81% | 100% |
A4I2H2 | Leishmania infantum | 92% | 100% |
C9ZX22 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 91% |
Q4Q8U6 | Leishmania major | 91% | 100% |